Latest Asx Listing Rules News

INOVIQ Limited clarifies recent share price movements, confirming no undisclosed material information while highlighting an imminent ASCO presentation and provisional patent application tied to its EXO-OC ovarian cancer test.

Locksley Resources has secured $1.47 million through a heavily subscribed placement to fund a critical minerals exploration campaign at its Mojave Project in California, targeting rare earth elements and antimony.

Western Mines Group has raised $1.287 million through a strategic placement to fast-track exploration at its flagship Mulga Tank project, signalling renewed momentum in its nickel and precious metals ambitions.

Coolabah Metals Limited is set to transform into a producing miner with its $15-20 million capital raise, conditional on acquiring Broken Hill Mines Pty Ltd and resuming ASX trading.

Axel REE Limited has responded to ASX Compliance queries confirming the timely disclosure of its latest rare earth element drilling results at the Poços de Caldas Caldera, emphasizing the incremental nature of the findings and ongoing compliance with listing rules.

Nufarm Limited confirms its half-year earnings align closely with analyst expectations despite a late-stage $16 million inventory valuation adjustment. The company maintains compliance with ASX disclosure rules amid market scrutiny.

Trinex Minerals is set to seek shareholder approval for a significant 127:1 share consolidation aimed at streamlining its capital structure and enhancing investor appeal. The move also adjusts options and performance rights accordingly.

Constellation Resources Limited is raising approximately $2.52 million through a non-renounceable entitlement offer priced at $0.12 per share, aiming to fund exploration projects in Western Australia and support general working capital.

Unith Ltd has responded to an ASX price query following unusual trading activity, denying undisclosed information and pointing to a successful recent roadshow as a potential factor.

West Wits Mining Limited (WWI) has addressed recent spikes in its share price and trading volume, linking the activity to funding developments, a strong gold price, and positive market commentary.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

Infomedia Ltd has responded to an ASX price query following a sharp share price decline and increased trading volume, denying any undisclosed material information. The company pointed to the recent closure of Celeste Funds, a known shareholder, as a potential external factor influencing market activity.